Jennifer Lynn Minai-Azary

Chief Financial Officer, Tempest Therapeutics, Inc.

Companies

Context Therapeutics Inc.Chief financial officer Nov 1, 2021 to now¹
Tempest Therapeutics, Inc.Chief financial officer Feb 9, 2021 to Mar 2, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Context Therapeutics Inc. CNTX80,010 shares³$19.2K at $0.24Jun 6, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 6, 2025Bought 40,010 shares at $0.64 of Context Therapeutics Inc.³
Dec 16, 2022Bought 25,000 shares at $0.74 of Context Therapeutics Inc.⁴
Aug 17, 2022Bought 15,000 shares at $1.80 of Context Therapeutics Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARContext Therapeutics Inc., Chief financial officer
2
SEC EDGARTempest Therapeutics, Inc., Chief financial officer
3
SEC EDGARContext Therapeutics Inc. shares after the filing of Jun 6, 2025
4
SEC EDGARForm 4 filed Dec 19, 2022
5
SEC EDGARForm 4 filed Aug 17, 2022